The global disposable EEG electrode market size was valued at USD 695.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.6% from 2021 to 2028. The demand for disposable EEG electrodes is increasing owing to technological advancements, an increasing number of HAIs cases, and the rising prevalence of neurological disorders across the globe. The increasing incidence of HAIs due to lack of sanitation and precaution is one of the leading factors contributing to the growth of the market for disposable EEG electrodes.
For instance, as per the CDC, about one in 25 hospital patients contracts at least one HAI every year. The use of disposable EEG electrodes helps to lower the risk of contracting HAIs. Furthermore, they also help to prevent the transmission of bacterial and other microbial infections from entering a patient’s body. Thus, healthcare professionals prefer to use disposable products over reusable ones. These factors are anticipated to propel the growth of the market for disposable EEG electrodes over the forecast period.
Increase in the prevalence of HAIs due to the use of reusable EEG electrodes is a key factor anticipated to propel market growth over the forecast period. According to a CDC report in 2018, around 1.7 million cases of HAIs and around 99,000 associated deaths are reported each year in American hospitals. As per a report published by European Centre for Disease Prevention and Control (ECDC), in 2018, the prevalence of HAIs in European countries was around 7.1%. It also reported that around 4,131,000 patients suffer from HAIs in Europe each year. Such cases are expected to increase the demand for disposable EEG electrodes.
Increasing prevalence of neurological diseases, such as Parkinson’s disease, epilepsy, essential tremor, and dystonia, is a high-impact driver of the market for disposable EEG electrodes. According to the WHO, neurological diseases contribute to 6.3% of the global healthcare burden. Neurological disease is one of the major causes of mortality worldwide. High mortality rate and disease burden create major demand for the incorporation of long-term solutions such as magnetic brain stimulators. Furthermore, growing awareness about this neurological disease burden has increased the demand for disposable EEG electrodes as an effective therapy.
Growing geriatric population directly amplifies the incidence of neurological diseases globally. Estimates published by the WHO suggest that the global base of population pertaining to the age group of 65 years and above is expected to increase from 7.00% in 2000 to 16.00% in 2050. The geriatric population is highly susceptible to these disorders, which is expected to be a key market driver. The growing geriatric population in Asian countries, such as Japan and China, holds major untapped opportunities, which are expected to drive the market during the forecast period.
The needle electrode segment dominated the market for disposable EEG electrodes and held the largest revenue share of 31.8% in 2020. The segment is expected to witness a considerable growth rate over the forecast period. The disposable needle EEG electrodes are used for direct cortical recordings and it is an invasive procedure. The skin preparation needs to be done before the actual procedure, in order to have better electrical conductivity between the skin surface and electrodes. The increasing cases of neurological disorders is one of the major factors driving the segment.
The cup electrode segment is anticipated to witness the fastest growth rate over the forecast period. Cup electrodes are designed to provide effectiveness, provide reliable signals, and are easy to use. The cup electrodes have several advantages which are as follows:
The risk of electrode lift and displacement-related re-application is minimized in these electrodes.
It allows a low electrode profile following the contours of the patient and provides reliable electric signals.
Such advantages of cup electrodes are anticipated to propel the growth of the segment over the forecast period.
The diagnostic segment dominated the market for disposable EEG electrodes and held the largest revenue share of 40.6% in 2020 and is anticipated to witness a considerable growth rate over the forecast period. The increasing cases of neurological disorders across the globe is the major factor driving the segment. According to the Anxiety and Depression Association of America (ADAA), anxiety disorder affects around 40.00 million adults aged 18 years or above every year. In addition, around 6.8 million adults are affected by Generalized Anxiety Disorder (GAD). Neurological disorders require an early diagnosis for effective treatment. Since disposable EEG electrode is majorly used for the early diagnosis, therefore, such factor is expected to drive the segment.
The therapeutic segment is anticipated to witness a considerable growth rate over the forecast period. The rising geriatric population across the globe is the major factor propelling the growth of the segment. The estimates by WHO suggest that the global population of people aged 65 years and older is expected to rise from 7.00% in 2000 to 16% in 2050. Old age increases predisposition to various conditions such as Parkinson’s and Alzheimer’s. Over the next 6 years, the growing global geriatric population is expected to serve this market as a high-impact rendering driver. Moreover, the high geriatric population in Asian countries, such as Japan and China present, presents large untapped opportunities. This is expected to drive the market during the forecast period.
The hospital segment dominated the market for disposable EEG electrodes and held the largest revenue share of 39.9% in 2020. The growth of this segment can be attributed to an upsurge in surgical procedures globally and an increase in the number of neurological disorders, which require the use of disposable EEG electrodes. Furthermore, the availability of technologically advanced disposable EEG electrodes will further enhance market growth during the forecast period. In addition, hospital institutions are considered as large buyers of disposable EEG electrodes having long-term contracts with suppliers, which enhances negotiating power of suppliers and creates a market for after-sales services.
The hospital segment is anticipated to witness the fastest growth rate over the forecast period. Increase in the number of hospitalizations worldwide and the rise in the adoption of technologically advanced products in hospitals are leading to an increase in the number of patients availing treatments in hospitals. Moreover, increasing healthcare expenditure in developed and developing countries might increase the number of hospitals owing to which demand for disposable EEG electrodes is also expected to increase.
North America dominated the disposable EEG electrode market in 2020 and accounted for the largest revenue share of 45.4%. The region is expected to witness a considerable growth rate of 3.7% over the forecast period. North America dominated the market owing to the increase in the prevalence of depression and Obsessive Compulsive Disorder (OCD) and the rise in demand for minimally invasive procedures. Technological advancements are also key factors contributing to the growth of the market in North America.
In Asia Pacific, the market for disposable EEG electrodes is anticipated to witness the fastest growth rate over the forecast period. Increasing prevalence of psychiatric and neurodegenerative disorders along with unmet demand for effective and long-term treatment solutions is expected to present significant growth opportunities for disposable EEG electrodes over this region. Moreover, rising preference for clinical trials and high R&D investments by global market players owing to their low-cost structure are factors driving the market in the region. Rising awareness about neurological disease treatment options and improvements in the clinical development framework of emerging economies are expected to drive market growth in this region.
Key players are involved in adopting strategies such as mergers and acquisitions, partnerships, and the launch of new products and services to strengthen their foothold in the market. For instance, in April 2020, Brain Scientific Inc. launched an online store to sell sanitized FDA-cleared NeuroCap and NeuroEEG. This may increase the customer pool of the company. Key players are also investing heavily in research and development to manufacture technologically advanced products. Some of the prominent players in the disposable EEG electrode market include:
Medtronic PLC
Ambu A/S
CONMED Corporation
BIOPAC Systems Inc.
Brain Scientific, Inc.
Natus Medical Incorporated
Report Attribute |
Details |
Market size value in 2021 |
USD 716.8 million |
Revenue forecast in 2028 |
USD 921.3 million |
Growth Rate |
CAGR of 3.6% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA) |
Country scope |
U.S.; Canada; U.K.; Germany; Japan; China; Brazil; Mexico; South Africa; Saudi Arabia |
Key companies profiled |
Medtronic PLC; CONMED Corporation; Natus Medical Incorporated; Brain Scientific, Inc.; Ambu A/S; BIOPAC Systems Inc. |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global disposable EEG electrode market report on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2016 - 2028)
Needle Electrodes
Patch Electrodes
Cup Electrodes
Disk Electrodes
Others
Application Outlook (Revenue, USD Million, 2016 - 2028)
Diagnostic
Therapeutic
End-use Outlook (Revenue, USD Million, 2016 - 2028)
Hospitals
Clinics
Others
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Saudi Arabia
b. North America dominated the disposable EEG electrode market with a share of 45% in 2020. This is attributable to the increasing prevalence of neurological diseases, such as Parkinson’s disease, epilepsy, essential tremor, and dystonia in the region.
b. Some key players operating in the disposable EEG electrode market include Medtronic PLC, CONMED Corporation, Natus Medical Incorporated, Brain Scientific, Inc., Ambu A/S, BIOPAC Systems Inc.
b. Key factors that are driving the disposable EEG electrode market growth include technological advancements, an increasing number of HAIs cases, and a rising prevalence of neurological disorders across the globe.
b. The global disposable EEG electrode market size was estimated at USD 695.6 million in 2020 and is expected to reach USD 716.8 million in 2021.
b. The global disposable EEG electrode market is expected to grow at a compound annual growth rate of 3.6% from 2021 to 2028 to reach USD 921.3 million by 2028.
b. The needle electrode segment dominated the global disposable EEG electrodes market and held the largest revenue share of 31.8% in 2020.
b. The diagnostic segment led the global disposable EEG electrodes market with a revenue share of 40.6% in 2020.
b. The hospital segment dominated the global disposable EEG electrodes market and held the largest revenue share of 39.9% in 2020.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."